Rule 9, Drugs (Prices Control) Order, 2013: Reference data and source of market based data
Drugs (Prices Control) Order, 2013 - Rule 9
Text of rule 9
Reference data and source of market based data
9. Reference data and source of market based data.– (1)
Initially, the source of market based data shall be the data available
with the pharmaceuticals market data specializing company – IMS
Health (IMS) and if the Government deems necessary, it may
validate such data by appropriate survey or evaluation.
(2) The Government may in the due course of time come out with
other appropriate mechanism of collecting or obtaining the market
based data related to drugs and the decision of Government with
respect to collection or obtaining of data shall be final.
(3) The market based data, for fixing the ceiling price of scheduled
formulations for the first time after the notification of this order,
shall be the data of May, 2012.
(4) The market based data for fixing the retail price of new drugs
available in the market, shall be the data available for the month
ending immediately before six months of receipt of application for
fixing the price of the new drug.
(5) The market based data for fixing the ceiling price of a scheduled
formulation due to a revision in the first schedule shall be the data
be taken for calculating the ceiling price of the scheduled formulation
under consideration.
(2) Notwithstanding anything contained in this paragraph, where the
price has been fixed and notified by the Government under the
Drugs (Prices Control) Order, 1995 the provisions of sub-paragraph
(1) shall not apply.
7. Margin to retailer.— While fixing a ceiling price of scheduled
formulations and retail prices of new drugs, sixteen percent of price
to retailer as a margin to retailer shall be allowed.
8. Maximum retail price.— (1) The maximum retail price of
scheduled formulations shall be fixed by the manufacturers on the
basis of ceiling price notified by the Government plus local taxes
wherever applicable, as under:
Maximum Retail Price = Ceiling price + Local Taxes as
applicable
(2) The maximum retail price of a new drug shall be fixed by the
manufacturers on the basis of retail price determined by the
Government plus local taxes wherever applicable, as under:
Maximum Retail Price = Retail Price + Local Taxes as
applicable
9. Reference data and source of market based data.- (1)
Initially, the source of market based data shall be the data available
with the pharmaceuticals market data specializing company - IMS
Health (IMS) and if the Government deems necessary, it may
validate such data by appropriate survey or evaluation.
(2) The Government may in the due course of time come out with
other appropriate mechanism of collecting or obtaining the market
based data related to drugs and the decision of Government with
respect to collection or obtaining of data shall be final.
(3) The market based data, for fixing the ceiling price of scheduled
formulations for the first time after the notification of this order,
Shall be the data of May, 2012.
(4) The market based data for fixing the retail price of new drugs
available in the market, shall be the data available for the month
ending immediately before six months of receipt of application for
fixing the price of the new drug.
(5) The market based data for fixing the ceiling price of a scheduled
formulation due to a revision in the first schedule shall be the data
available for the month ending immediately before six month of
notification of revision in the first schedule.
(6) Notwithstanding anything contained in this order, the reference
date for the formulations which are part of the Drugs (Prices Control)
Order, 1995 shall be as per the provisions of paragraph 10 of this
Order.
Previous and next
Questions people ask
Is rule 9 of Drugs (Prices Control) Order, 2013 still in force?
No repeal of Drugs (Prices Control) Order, 2013 is recorded.